• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9010
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Thrombosis/Thrombus (4440); Restenosis (4576)
Date of Event 07/20/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported through the results of a clinical trial that ten months and two days post an index procedure completion using a drug-coated balloon catheter in the cephalic vein via the left upper arm, the subject had an adverse event of stenosis at cephalic arch and swing arm in arteriovenous fistula.It was further reported that the target lesion was in the upper arm with fifty-two percent initial stenosis and twenty percent final residual stenosis.Reportedly, standard percutaneous transluminal angioplasty was performed for treatment.Treatment reintervention was successful, and the outcome of the serious adverse event was resolved.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H10: d4 (expiration date: 01/2024) h11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through the results of a clinical trial that approximately ten months and two days post index procedure using a drug-coated balloon catheter in the cephalic vein, the subject had an adverse event of stenosis at cephalic arch and swing arm in arteriovenous fistula.It was further reported that the target lesion was in the upper arm with fifty-two percent initial stenosis and twenty percent final residual stenosis.Reportedly, standard percutaneous transluminal angioplasty was used for treatment.It was further reported that approximately one year nine months and fourteen days post index procedure, the subject had an adverse event of thrombosis of the arteriovenous fistula.Reportedly, the adverse event was not related to the device and procedure but possibly related to the av access circuit.Furthermore, thrombectomy/thrombolysis was performed for target lesion with initial stenosis of hundred percent and final residual stenosis of sixty percent and access thrombosis with initial stenosis of hundred percent and final residual stenosis of sixty percent.The re-intervention was successful, and the outcome of the adverse event was resolved.The current status of the patient was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035AV DRUG COATED PTA DILATION CATHETER
Common Device Name
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
LUTONIX, INC
9409 science center dr
new hope MN 55428
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key19605145
Report Number3006513822-2024-00033
Device Sequence Number18187293
Product Code PRC
UDI-Device Identifier00801741135484
UDI-Public(01)00801741135484(17)240117(10)GFFY0804
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
P170003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/17/2024
Device Model Number9010
Device Catalogue NumberLX3575940V
Device Lot NumberGFFY0804
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/29/2024
Supplement Date Received by Manufacturer10/14/2024
Initial Report FDA Received Date06/25/2024
Supplement Report FDA Received Date11/07/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age37 YR
Patient SexFemale
Patient Weight73 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-